Kristina Shultz is an Associate Vice President at AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed). AdvaMedDx represents over 70 manufacturers of innovative in vitro diagnostic (IVD) tests in the U.S. and abroad. In this role, Kristina works to advance the public policy priorities of AdvaMedDx members through education, advocacy, policy development, communications, and connectivity with public and private sector stakeholders. Kristina leads AdvaMedDx’s work on public health issues of concern, including COVID-19, influenza, and antimicrobial resistance.
Prior to this role, Kristina held several other positions within AdvaMed since joining the association in 2014. Kristina has extensive experience providing research, strategic planning, and content development across all of AdvaMed’s departments, divisions, and sectors. Kristina previously helped launch and operate AdvaMed’s Diabetes Sector, Research & Development Forum, and Center for Digital Health.
Kristina holds a bachelor’s degree in human biology from Cornell University and a Masters of Public Health with a concentration in epidemiology from Johns Hopkins University.